Liver toxicity related to herbs and dietary supplements: Online table of case reports. Part 2 of 5 series

Food and Chemical Toxicology

Volumn 107, Issue , 2017, Pages 472-501

  Brown, Amy Christine ^a  

^a UNIVERSITY OF HAWAII   (United States)

Author keywords

Dietary supplement; Hepatitis; Hepatotoxicity; Herb; Liver; Toxicity

Indexed keywords

HERBACEOUS AGENT; KAVA EXTRACT; NICOTINIC ACID; RETINOL; SINECATECHINS; USNIC ACID; PLANT EXTRACT;

ACTAEA RACEMOSA; ACUTE LIVER FAILURE; ADVERSE OUTCOME; AFRICA; ASIA; CAUSALITY; CHOLESTASIS; DEATH; DIETARY SUPPLEMENT; DRUG SURVEILLANCE PROGRAM; GERMANDER; HEPATITIS; HERB; HUMAN; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; LIVER INJURY; LIVER NECROSIS; LIVER TOXICITY; PREVALENCE; PUBLICATION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SOUTH AMERICA; STEATOSIS; TOXIC HEPATITIS; VEIN OCCLUSION; DRUG EFFECTS; LIVER; STANDARDS; TOXICITY;

CHEMICAL AND DRUG INDUCED LIVER INJURY; DIETARY SUPPLEMENTS; HUMANS; LIVER; PLANT EXTRACTS;

EID: 85017386193     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2016.07.001     Document Type: Review

References (349)

1. Abu el, Wafa Y., Benavente, Fernández A., Talavera, Fabuel A., Pérez, Ramos MA., Ramos-Clemente, J.I., Acute hepatitis induced by Camellia sinensis (green tea). An Med Interna, 22(6), 2005, 298 [Article in Spanish].
2. Adachi, M., Saito, H., Kobayashi, H., Horie, Y., Kato, S., Yoshioka, M., Ishii, H., Hepatic injury in 12 patients taking the herbal weight loss AIDS Chaso or Onshido. Ann Intern Med. 139:6 (2003), 488–492.
3. Alderman, S., Kailas, S., Goldfarb, S., Singaram, C., et al. Cholestatic hepatitis after ingestion of chaparral leaf: confirmation by endoscopic retrograde cholangiopancreatography and liver biopsy. Am. J. Gastroenterol. 19:3 (1994), 242–247.
4. Anderson, I.B., Mullen, W.H., Meeker, J.E., Khojasteh-Bakht, S.C., Oishi, S., Nelson, S.D., Blanc, P.D., Pennyroyal toxicity: measurement of toxic metabolite levels in two cases and review of the literature. Ann. Intern Med. 124:8 (1996), 726–734.
5. Andrade, R.J., Lucena, M.I., Fernández, M.C., Pelaez, G., Pachkoria, K., García-Ruiz, E., García-Muñoz, B., González-Grande, R., Pizarro, A., Durán, J.A., Jiménez, M., Rodrigo, L., Romero-Gomez, M., Navarro, J.M., Planas, R., Costa, J., Borras, A., Soler, A., Salmerón, J., Martin-Vivaldi, R., Spanish Group for the Study of Drug-Induced Liver Disease. Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology 129:2 (2005), 512–521.
6. Andrade, R.J., López-Ortega, S., López-Vega, M.C., Robles, M., Cueto, I., Lucena, M.I., Idiosyncratic drug hepatotoxicity: a 2008 update. Expert Rev. Clin. Pharmacol. 1:2 (2008), 261–276.
7. Apestegui, C.A., Julliard, O., Ciccarelli, O., etal, Energy drinks: another red flag for the liver allograft. Liver Transpl. 17 (2011), 1117–1118.
8. Appelhans, K., Smith, C., Bejar, E., Henig, Y.S., Revisiting acute liver injury associated with herbalife products. World J. Hepatol. 3:10 (2011), 275–277.
9. Araujo, J.L., Worman, H.J., Acute liver injury associated with a newer formulation of the herbal weight loss supplement Hydroxycut. BMJ Case Rep., 2015, 2015.
10. Au, J.S., Navarro, V.J., Rossi, S., Review article: drug-induced liver injury–its pathophysiology and evolving diagnostic tools. Aliment. Pharmacol. Ther. 34:1 (2011), 11–20.
11. Bach, N., Thung, S.N., Schaffner, F., Comfrey herb tea-induced hepatic veno-occlusive disease. Am. J. Med. 87:1 (1989), 97–99.
12. Bajaj, J., Knox, J.F., Komorowski, R., Saeian, K., The irony of herbal hepatitis. Ma-huang-induced haptotoxicity associated with compound heterozygosity for hereditary hemochromatosis. Dig. Dis. Sci. 48:10 (2003), 1925–1928.
13. Barakat, S.E., Adam, S.E., Maglad, M.A., Wasfi, I.A., Effects of Cissus quadrangularis on goats and sheep in Sudan. Rev. Elev. Med. Vet. Pays Trop. 38:2 (1985), 185–194.
14. Barker, J., Horn, E.J., Lebwohl, M., Warren, R.B., Nast, A., Rosenberg, W., Smith, C., International Psoriasis Council. Assessment and management of methotrexate hepatotoxicity in psoriasis patients: report from a consensus conference to evaluate current practice and identify key questions toward optimizing methotrexate use in the clinic. J. Eur. Acad. Derm. Venereol. 25:7 (2011), 758–764.
15. Bakerink, J.A., Gospe, S.M. Jr., Dimand, R.J., Eldridge, M.W., Multiple organ failure after ingestion of pennyroyal oil from herbal tea in two infants. Pediatrics 98:5 (1996), 944–947.
16. Banarova, A., Koller, T., Payer, J., Toxic hepatitis induced by Polygonum multiflorum. Vnitr Lek. 58:12 (2012), 958–962 [Article in Slovak].
17. Bassan, M., A case for immediate-release niacin. Heart Lung 41:1 (2012), 95–98.
18. Batchelor, W.B., Heathcote, J., Wanless, I.R., Chaparral-induced hepatic injury. Am. J. Gastroenterol. 90:5 (1995), 831–833.
19. Belfrage, B., Malmström, R., Several cases of liver affected by aloe vera. Lakartidningen, 105(1–2), 2008, 45 [Article in Swedish].
20. Bonkovsky, H.L., Hepatotoxicity associated with supplements containing Chinese green tea (Camellia sinensis). Ann. Intern Med. 144:1 (2006), 68–71.
21. Benninger, J., Schneider, H.T., Schuppan, D., Kirchner, T., et al. Acute hepatitis induced by greater celandine (Cheliodonium majus). Gastroenterology 117:5 (1999), 1234–1237.
22. Ben Yahia, M., Mavier, P., Métreau, J.M., Zafrani, E.S., Fabre, M., Gatineau-Saillant, G., Dhumeaux, D., Mallat, A., Chronic active hepatitis and cirrhosis induced by wild germander. 3 cases. Gastroenterol. Clin. Biol. 17:12 (1993), 959–962 [Article in French].
23. Beuers, U., Spengler, U., Pape, G.R., Hepatitis after chronic abuse of senna. Lancet 337 (1991), 372–373.
24. Bilal, M., Patel, Y., Burkitt, M., Babich, M., Linoleic acid induced acute hepatitis: a case report and review of the literature. Case Rep. Hepatol., 2015, 2015, 807354.
25. Björnsson, E.S., Bergmann, O.M., Björnsson, H.K., Kvaran, R.B., Olafsson, S., Incidence, presentation, and outcomes in patients with drug-induced liver injury in the general population of Iceland. Gastroenterology, 144(7), 2013 1419–25, 1425.e1-3; quiz e19–20.
26. Borum, M.L., Fulminant exacerbation of autoimmune hepatitis after the use of ma huang. Am. J. Gastroenterol. 96:5 (2001), 1654–1655.
27. Bottenberg, M.M., Wall, G.C., Harvey, R.L., Habib, S., Oral aloe vera-induced hepatitis. Ann. Pharmacother. 41:10 (2007), 1740–1743.
28. Brauer, R.B., Stangl, M., Stewart, J.R., Pfab, R., Becker, K., Acute liver failure after administration of herbal tranquilizer kava-kava (Piper methysticum). J. Clin. Psychiatry 64 (2003), 216–218.
29. Brent, J., Three new herbal hepatotoxic syndromes. J. Toxicol. Clin. Toxicol. 37:6 (1999), 715–719.
30. Brown, A.C., An overview of herb and dietary supplement efficacy, safety, and regulations in the United States with suggested improvements. Part 1 of 5 Series. Food Chem Toxicol. 107 (2017), 449–471.
31. Brown, A.C., Liver toxicity related to herbs and dietary supplements: online table of case reports. Part 2 of 5 series. Food Chem Toxicol. 107 (2017), 472–501.
32. Brown, A.C., Kidney toxicity related to herbs and dietary supplements: online table of case reports. Part 3 of 5 series. Food Chem Toxicol. 107 (2017), 502–519.
33. Brown, A.C., Heart toxicity related to herbs and dietary supplements: online table of case reports. Part 4 of 5 series. Food Chem Toxicol., 2017 (in press).
34. Brown, A.C., Cancer related to herbs and dietary supplements: online table of case reports. Part 5 of 5 series. Food Chem Toxicol., 2017 (in press).
35. Bunchorntavakul, C., Reddy, K.R., Review article: herbal and dietary supplement hepatotoxicity. Aliment. Pharmacol. Ther. 37:1 (2013), 3–17.
36. Bujanda, L., Palacios, A., Sil varino, R., Sanchez, A., Munoz, C., Kava-induced acute icteric hepatitis. Gastroenterol. Hepatol. 25 (2002), 434–435.
37. Campbell, T.C., Hayes, J.R., Role of nutrition in the drug-metabolizing enzyme system. Pharmacol. Rev. 26:3 (1974), 171–197.
38. Caravaca-Magarios, F., Cubero-Gomez, J.J., Arrobsvaca, M., Renal and hepatic injuries in human intoxication with Atractylis gummifera. Nefrologia, 5, 1985 205–201.
39. Carey, E.J., Vargas, H.E., Douglas, D.D., Balan, V., Byrne, T.J., Harrison, M.E., Rakela, J., Inpatient admissions for drug-induced liver injury: results from a single center. Dig. Dis. Sci. 53:7 (2008), 1977–1982.
40. Castaño, G., Etchart, C., Sookoian, S., Vitamin A toxicity in a physical culturist patient: a case report and review of the literature. Ann. Hepatol. 5:4 (2006), 293–395.
41. Castot, A., Larrey, D., Hepatitis observed during a treatment with a drug or tea containing Wild Germander. Evaluation of 26 cases reported to the Regional Centers of Pharmacovigilance. Gastroenterol. Clin. Biol. 16:12 (1992), 916–922 [French].
42. Catanzano, G., Delons, S., Benyahia, T.D., 2 cases of poisoning due to “gum thistle” (Atractylis gummifera L.). Clinical development and anatomo-pathologic lesions. Maroc. Med. 49:529 (1969), 651–655 [Article in French].
43. CDC (Centers of Disease Control & Prevention), Chaparral-induced toxic hepatitis–California and Texas, 1992. MMWR Morb. Mortal. Wkly. Rep. 41:43 (1992), 812–814.
44. CDC, Chronic liver disease and cirrhosis. 2013 https://www.cdc.gov/nchs/fastats/liver-disease.htm.
45. CDC, Hepatic toxicity possibly associated with kava-containing products–United States, Germany, and Switzerland, 1999-2002. MMWR Morb. Mortal. Wkly. Rep. 51:47 (2002), 1065–1067.
46. CDC, Hepatitis temporally associated with an herbal supplement containing artemisinin - Washington, 2008. MMWR Morb. Mortal. Wkly. Rep. 58:31 (2009), 854–856.
47. Cerda, C., Burguera, M., Pares, A., Hepatotoxicity associated with glucosamine and chondroitin sulfate in patients with chronic liver disease. World J. Gastroenterol. 19:32 (2013), 5381–5384.
48. Chalasani, N., Björnsson, E., Risk factors for idiosyncratic drug-induced liver injury. Gastroenterology 138:7 (2010), 2246–2259.
49. Chalasani, N., Bonkovsky, H.L., Fontana, R., Lee, W., Stolz, A., Talwalkar, J., Reddy, K.R., Watkins, P.B., Navarro, V., Barnhart, H., Gu, J., Serrano, J., United States drug induced liver injury network. Features and outcomes of 899 patients with drug-induced liver injury: the DILIN prospective study. Gastroenterology, 148(7), 2015 1340–52.e7.
50. Chalasani, N., Fontana, R.J., Bonkovsky, H.L., Watkins, P.B., Davern, T., Serrano, J., Yang, H., Rochon, J., Drug Induced Liver Injury Network (DILIN). Causes, clinical features, and outcomes from a prospective study of drug-induced liver injury in the United States. Gastroenterology, 135(6), 2008 1924–34, 1934.
51. Chalasani, N.P., Hayashi, P.H., Bonkovsky, H.L., Navarro, V.J., Lee, W.M., Fontana, R.J., Practice parameters committee of the American College of Gastroenterology. ACG clinical guideline: the diagnosis and management of idiosyncratic drug-induced liver injury. Am. J. Gastroenterol., 109(7), 2014 950–66; quiz 967.
52. Chalasani, N., Vuppalanchi, R., Navarro, V., Fontana, R., Bonkovsky, H., Barnhart, H., Kleiner, D.E., Hoofnagle, J.H., Acute liver injury due to flavocoxid (Limbrel), a medical food for osteoarthritis: a case series. Ann. Intern Med., 156(12), 2012 857–60, W297-300.
53. Chao, S., Anders, M., Turbay, M., Olaiz, E., Mc Cormack, L., Mastai, R., [Toxic hepatitis by consumption Herbalife products a case report]. [Article Span. Acta Gastroenterol Latinoam 38:4 (2008), 274–277.
54. Chen, G.C., Ramanathan, V.S., Law, D., Funchain, P., Chen, G.C., French, S., Shlopov, B., Eysselein, V., Chung, D., Reicher, S., Pham, B.V., Acute liver injury induced by weight-loss herbal supplements. World J. Hepatol. 2:11 (2010), 410–415.
55. Chen, M., Borlak, J., Tong, W., High lipophilicity and high daily dose of oral medications are associated with significant risk for drug-induced liver injury. Hepatology 58:1 (2013), 388–396.
56. Cheng, F.K., Dunaway, P., A case of supplement-induced hepatotoxicity. Case Rep. Med., 2010, 2010 pii: 262706.
57. Cheruvattath, R., Orrego, M., Gautam, M., Byrne, T., Alam, S., Voltchenok, M., Edwin, M., Wilkens, J., Williams, J.W., Vargas, H.E., Vitamin A toxicity: when one a day doesn't keep the doctor away. Liver Transpl. 12:12 (2006), 1888–1891.
58. Chitturi, S., Farrell, G.C., Hepatotoxic slimming aids and other herbal hepatotoxins. J. Gastroenterol. Hepatol. 23:3 (2008), 366–373.
59. Chiu, Y.K., Lai, M.S., Ho, J.C., Chen, J.B., Acute fish liver intoxication: report of three cases. Chang. Yi Xue Za Zhi 22:3 (1999), 468–473.
60. Chojkier, M., Hepatic sinusoidal-obstruction syndrome: toxicity of pyrrolizidine alkaloids. J. Hepatol. 39:3 (2003), 437–446.
61. Chow, E.C., Teo, M., Ring, J.A., Chen, J.W., Liver failure associated with the use of black cohosh for menopausal symptoms. Med. J. Aust. 188:7 (2008), 420–422.
62. Christl, S.U., Seifert, A., Seeler, D., Toxic hepatitis after consumption of traditional kava preparation. J. Travel Med. 16:1 (2009), 55–56.
63. Church, R.J., Gatti, D.M., Urban, T.J., Long, N., Yang, X., Shi, Q., Eaddy, J.S., Mosedale, M., Ballard, S., Churchill, G.A., Navarro, V., Watkins, P.B., Threadgill, D.W., Harrill, A.H., Sensitivity to hepatotoxicity due to epigallocatechin gallate is affected by genetic background in diversity outbred mice. Food Chem. Toxicol. 76 (2015), 19–26.
64. Cohen, D.L., Del Toro, Y., A case of valerian-associated hepatotoxicity. J. Clin. Gastroenterol. 42:8 (2008), 961–962.
65. Cohen, S.M., O'Connor, A.M., Hart, J., Merel, N.H., Te, H.S., Autoimmune hepatitis associated with the use of black cohosh: a case study. Menopause 11:5 (2004), 575–577.
66. Cooke, C., Carr, I., Abrams, K., Mayberry, J., Arrowroot as a treatment for diarrhoea in irritable bowel syndrome patients: a pilot study. Arq. Gastroenterol. 37:1 (2000), 20–24.
67. Crijns, A.P., de Smet, P.A., van den Heuvel, M., Schot, B.W., Haagsma, E.B., Acute hepatitis after use of a herbal preparation with greater celandine (Chelidonium majus). Ned. Tijdschr. Geneeskd. 146:3 (2002), 124–128 [Article in Dutch].
68. Curciarello, J., De Ortúzar, S., Borzi, S., Bosia, D., Severe acute hepatitis associated with intake of Aloe vera tea. Gastroenterol. Hepatol. 31 (2008), 436–438 [Article in Spanish].
69. Dantuluri, S., North-Lewis, P., Karthik, S.V., Gotu Kola induced hepatotoxicity in a child - need for caution with alternative remedies. Dig. Liver Dis., 43(6), 2011, 500.
70. Dara, L., Hewett, J., Lim, J.K., Hydroxycut hepatotoxicity: a case series and review of liver toxicity from herbal weight loss supplements. World J. Gastroenterol. 14:45 (2008), 6999–7004.
71. Dasgupta, A., Bernard, D.W., Herbal remedies: effects on clinical laboratory tests. Arch. Pathol. Lab. Med. 130:4 (2006), 521–528.
72. Davis, D.C., Potter, W.Z., Jollow, D.J., Mitchell, J.R., Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci. 14:11 (1974), 2099–2109.
73. Dao, T., Peytier, A., Galateau, F., Valla, A., Chronic cirrhogenic hepatitis induced by germander. Gastroenterol. Clin. Biol. 17:8–9 (1993), 609–610 [Article in French].
74. De Smet, P.A., Van den Eertwegh, A.J., Lesterhuis, W., Stricker, B.H., Hepatotoxicity associated with herbal tablets. BMJ, 313(7049), 1996, 92.
75. Diaz, D., Ferroudji, S., Heran, B., Barneon, G., Larrey, D., Michel, H., Fulminant hepatitis caused by wild germander. Gastroenterol. Clin. Biol. 16:12 (1992), 1006–1007 [Article in French].
76. Dong, H., Slain, D., Cheng, J., Ma, W., Liang, W., Eighteen cases of liver injury following ingestion of Polygonum multiflorum. Complement. Ther. Med. 22:1 (2014), 70–74.
77. Dourakis, S.P., Papanikolaou, I.S., Tzemanakis, E.N., Hadziyannis, S.J., Acute hepatitis associated with herb (Teucrium capitatum L.) administration. Eur. J. Gastroenterol. Hepatol. 14:6 (2002), 693–695.
78. Duque, J.M., Ferreiro, J., Salgueiro, E., Manso, G., Hepatotoxicity associated with the consumption of herbal slimming products. Med. Clin. Barc. 128:6 (2007), 238–239 [Article in Spanish].
79. Durazo, F.A., Lassman, C., Han, S.H., Saab, S., Lee, N.P., Kawano, M., Saggi, B., Gordon, S., Farmer, D.G., Yersiz, H., Goldstein, R.L., Ghobrial, M., Busuttil, R.W., Fulminant liver failure due to usnic acid for weight loss. Am. J. Gastroenterol. 99:5 (2004), 950–952.
80. Ebrahim, V., Albeldawi, M., Chiang, D.J., Acute liver injury associated with glucosamine dietary supplement. BMJ Case Rep., 2012, 2012.
81. Elinav, E., Pinsker, G., Safadi, R., Pappo, O., Bromberg, M., Anis, E., Keinan-Boker, L., Broide, E., Ackerman, Z., Kaluski, D.N., Lev, B., Shouval, D., Association between consumption of Herbalife nutritional supplements and acute hepatotoxicity. J. Hepatol. 47:4 (2007), 514–520.
82. Ellsworth, M.A., Anderson, K.R., Hall, D.J., Freese, D.K., Lloyd, R.M., Acute liver failure secondary to niacin toxicity. Case Rep. Pediatr., 2014, 2014, 692530.
83. Enbom, E.T., Le, M.D., Oesterich, L., Rutgers, J., French, S.W., Mechanism of hepatotoxicity due to black cohosh (Cimicifuga racemosa): histological, immunohistochemical and electron microscopy analysis of two liver biopsies with clinical correlation. Exp. Mol. Pathol. 96:3 (2014), 279–283.
84. Escher, M., Desmeules, J., Giostra, E., Mentha, G., Hepatitis associated with Kava, a herbal remedy for anxiety. BMJ, 322(7279), 2001, 139.
85. Estes, J.D., Stolpman, D., Olyaei, A., Corless, C.L., Ham, J.M., Schwartz, J.M., Orloff, S.L., High prevalence of potentially hepatotoxic herbal supplement use in patients with fulminant hepatic failure. Arch. Surg. 138:8 (2003), 852–858.
86. European Commission, Commission Decisions of 5 June 2003 authorizing the placing on the market of “noni juice” (juice of the fruit of Morinda citrifolia L.) as a novel food ingredient under Regulation (EC) Nr. 258/97 of the European Parliament and of the Council. Official Journal of the European Union 2003; L 144/12:12.6.2003.
87. European Commission on Health and Consumer Protection Directorate-General, Opinion of the Scientific Committee on Food on Tahitian Noni Juice. 2002 Available at: http://ec.europa.eu/food/fs/sc/scf/out151_en.pdf.
88. Farina, E.K., Austin, K.G., Lieberman, H.R., Concomitant dietary supplement and prescription medication use is prevalent among US adults with doctor-informed medical conditions. J. Acad. Nutr. Diet., 114(11), 2014 1784–90.e2.
89. Favreau, J.T., Ryu, M.L., Braunstein, G., Orshansky, G., Park, S.S., Coody, G.L., Love, L.A., Fong, T.L., Severe hepatotoxicity associated with the dietary supplement LipoKinetix. Ann. Intern Med. 136:8 (2002), 590–595.
90. FDA-a, Drug-induced Liver Toxicity. 08/05/2015 http://www.fda.gov/Drugs/ScienceResearch/ResearchAreas/ucm071471.htm (accessed 15.12.15.).
91. FDA-b, Guidance for Industry. Drug-induced Liver Injury: Premarketing Clinical Evaluation. 2009, US Department of Health and Human Services, FDA, CDER, CBER.
92. FDA-c, Lipkinetix. 08/16/2013 http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm172824.htm (accessed 01.12.15.).
93. FDA-d, Postmarketing Surveillance Programs. 2014, FDA http://www.fda.gov/Drugs/GuidanceComplianceRegulatoryInformation/Surveillance/ucm090385.htm (accessed 06.26.16.).
94. Federico, A., Tiso, A., Loguercio, C., A case of hepatotoxicity caused by green tea. Free Radic. Biol. Med., 43(3), 2007, 474.
95. Fernández, J., Navascués, C., Albines, G., Franco, L., Pipa, M., Rodríguez, M., Three cases of liver toxicity with a dietary supplement intended to stop hair loss. Rev. Esp. Enferm. Dig. 106:8 (2014), 552–555.
96. Ferrucci, L.M., Bell, B.P., Dhotre, K.B., Manos, M.M., Terrault, N.A., Zaman, A., Murphy, R.C., Vanness, G.R., Thomas, A.R., Bialek, S.R., Desai, M.M., Sofair, A.N., Complementary and alternative medicine use in chronic liver disease patients. J. Clin. Gastroenterol. 44:2 (2010), e40–e45.
97. Fischer, D.J., Knight, L.L., Vestal, R.E., Fulminant hepatic failure following low-dose sustained-release niacin therapy in hospital. West. J. Med. 155:4 (1991), 410–412.
98. Foley, S., Butlin, E., Shields, W., Lacey, B., Experience with OxyELITE pro and acute liver injury in active duty service members. Dig. Dis. Sci. 59:12 (2014), 3117–3121.
99. Fong, T.L., Klontz, K.C., Canas-Coto, A., Casper, S.J., Durazo, F.A., Davern, T.J. 2nd, Hayashi, P., Lee, W.M., Seeff, L.B., Hepatotoxicity due to hydroxycut: a case series. Am. J. Gastroenterol. 105:7 (2010), 1561–1566.
100. Fontana, R.J., Hayashi, P.H., Gu, J., Reddy, K.R., Barnhart, H., Watkins, P.B., Serrano, J., Lee, W.M., Chalasani, N., Stolz, A., Davern, T., Talwakar, J.A., DILIN Network. Idiosyncratic drug-induced liver injury is associated with substantial morbidity and mortality within 6 months from onset. Gastroenterology 147:1 (2014), 96–108.
101. Fontana, R.J., Seeff, L.B., Andrade, R.J., Björnsson, E., Day, C.P., Serrano, J., Hoofnagle, J.H., Standardization of nomenclature and causality assessment in drug-induced liver injury: summary of a clinical research workshop. Hepatology 52:2 (2010), 730–742.
102. Forouhar, F., Nadel, M.S., Gondos, B., Hepatic pathology in vitamin A toxicity. Ann. Clin. Lab. Sci. 14:4 (1984), 304–310.
103. Fox, D.W., Hart, M.C., Bergeson, P.S., Jarrett, P.B., Stillman, A.E., Huxtable, R.J., Pyrrolizidine (Senecio) intoxication mimicking Reye syndrome. J. Pediatr. 93:6 (1978), 980–982.
104. Fu, P.P., Xia, Q., Lin, G., Chou, M.W., Pyrrolizidine alkaloids–genotoxicity, metabolism enzymes, metabolic activation, and mechanisms. Drug Metab. Rev. 36:1 (2004), 1–55.
105. Fujii, H., Takagaki, N., Yoh, T., Morita, A., Ohkawara, T., Yamaguchi, K., Minami, M., Sawa, Y., Okanoue, T., Ohkawara, Y., Itoh, Y., Non-prescription supplement-induced hepatitis with hyperferritinemia and mutation (H63D) in the HFE gene. Hepatol. Res. 38:3 (2008), 319–323.
106. García-Cortés, M., Stephens, C., Lucena, M.I., Fernández-Castañer, A., Andrade, R.J., Spanish Group for the Study of Drug-Induced Liver Disease (Grupo de Estudio para las Hepatopatías Asociadas a Medicamentos GEHAM). Causality assessment methods in drug induced liver injury: strengths and weaknesses. J. Hepatol. 55:3 (2011), 683–691.
107. García-Cortés, M., Borraz, Y., Lucena, M.I., Peláez, G., Salmerón, J., Diago, M., Martínez-Sierra, M.C., Navarro, J.M., Planas, R., Soria, M.J., Bruguera, M., Andrade, R.J., Liver injury induced by “natural remedies”: an analysis of cases submitted to the Spanish Liver Toxicity Registry. Rev. Esp. Enferm. Dig. 100:11 (2008), 688–695 [Article in Spanish].
108. Garrido-Gallego, F., Muñoz-Gómez, R., Muñoz-Codoceo, C., Delgado-Álvarez, P., Fernández-Vázquez, I., Castellano, G., Acute liver failure in a patient consuming Herbalife products and Noni juice. Rev. Esp. Enferm. Dig. 107:4 (2015), 247–248.
109. Georgiou, M., Sianidou, L., Hatzis, T., Papadatos, J., Koutselinis a hepatotoxicity due to Atractylis gummifera-L. J. Toxicol. Clin. Toxicol. 26:7 (1988), 487–493.
110. Geubel, A.P., De Galocsy, C., Alves, N., Rahier, J., Dive, C., Liver damage caused by therapeutic vitamin A administration: estimate of dose-related toxicity in 41 cases. Gastroenterology 100:6 (1991), 1701–1709.
111. Gloro, R., Hourmand-Ollivier, I., Mosquet, B., Mosquet, L., Rousselot, P., Salamé, E., Piquet, M.A., Dao, T., Fulminant hepatitis during self-medication with hydroalcoholic extract of green tea. Eur. J. Gastroenterol. Hepatol. 17:10 (2005), 1135–1137.
112. Goksu, E., Kilic, T., Yilmaz, D., Hepatitis: a herbal remedy Germander. Clin. Toxicol. (Phila), 50(2), 2012, 158.
113. Gordon, D.W., et al. Chaparral ingestion. The broadening spectrum of liver injury caused by herbal medications. JAMA 273:6 (1995), 489–490.
114. Gori, L., Galluzzi, P., Mascherini, V., Gallo, E., Lapi, F., Menniti-Ippolito, F., Raschetti, R., Mugelli, A., Vannacci, A., Firenzuoli, F., Two contemporary cases of hepatitis associated with Teucrium chamaedrys L. decoction use: case reports and review of literature. Basic Clin. Pharmacol. Toxicol. 109:6 (2011), 521–526.
115. Gow, P.J., Connelly, N.J., Hill, R.L., Crowley, P., Angus, P.W., Fatal fulminant hepatic failure induced by a natural therapy containing kava. Med. J. Aust. 178 (2003), 442–443.
116. Guan, Y.S., A case report of hepatic veno-occlusive disease after ingesting dainties. World J. Gastroenterol. 12:41 (2006), 6734–6735.
117. Gunawan, B., Kaplowitz, N., Clinical perspectives on xenobiotic-induced hepatotoxicity. Drug Metab. Rev. 36:2 (2004), 301–312.
118. Guévart, E., Aguémon, A., Two cases of fulminant hepatitis during a curative treatment with an artesunate-amodiaquine combination. Med. Mal. Infect. 39:1 (2009), 57–60 [Article in French].
119. Guo, L., Shi, Q., Fang, J.L., Mei, N., Ali, A.A., Lewis, S.M., Leakey, J.E., Frankos, V.H., Review of usnic acid and Usnea barbata toxicity. J. Environ. Sci. Health C Environ. Carcinog. Ecotoxicol. Rev. 26:4 (2008), 317–338.
120. Guzman, G., Kallwitz, E.R., Wojewoda, C., Chennuri, R., Berkes, J., Layden, T.J., Cotler, S.J., Liver injury with features mimicking autoimmune hepatitis following the use of black cohosh. Case Rep. Med., 2009, 2009, 918156.
121. Haaz, S., Fontaine, K.R., Cutter, G., Limdi, N., Perumean-Chaney, S., Allison, D.B., Citrus aurantium and synephrine alkaloids in the treatment of overweight and obesity: an update. Obes. Rev. 7:1 (2006), 79–88.
122. Haimowitz, S., Hsieh, J., Shcherba, M., Averbukh, Y., Liver failure after Hydroxycut™ use in a patient with undiagnosed hereditary coproporphyria. J. Gen. Intern Med. 30:6 (2015), 856–859.
123. Hamid, S., Rojter, S., Vierling, J., Protracted cholestatic hepatitis after the use of prostata. Ann. Intern Med. 127:2 (1997), 169–170.
124. Hamouda, C., Amamou, M., Thabet, H., Yacoub, M., Hedhili, A., Bescharnia, F., Ben Salah, N., Zhioua, M., Abdelmoumen, S., El Mekki Ben Brahim, N., Plant poisonings from herbal medication admitted to a Tunisian toxicologic intensive care unit, 1983-1998. Vet. Hum. Toxicol. 42:3 (2000), 137–141.
125. Hamouda, C., Hédhili, A., Ben Salah, N., Zhioua, M., Amamou, M., A review of acute poisoning from Atractylis gummifera L. Vet. Hum. Toxicol. 46:3 (2004), 144–146.
126. Hardeman, E., Van Overbeke, L., Ilegems, S., Ferrante, M., Acute hepatitis induced by greater celandine (Chelidonium majus). Acta Gastroenterol. Belg 71:2 (2008), 281–282.
127. Harvey, J., Colin-Jones, D.G., Mistletoe hepatitis. Br. Med. J. Clin. Res. Ed. 282:6259 (1981), 186–187.
128. Hayman, R.M., Dalziel, S.R., Acute vitamin A toxicity: a report of three paediatric cases. J. Paediatr. Child. Health 48:3 (2012), E98–E100.
129. Horowitz, R.S., Feldhaus, K., Dart, R.C., Stermitz, F.R., Beck, J.J., The clinical spectrum of Jin Bu Huan toxicity. Arch. Intern Med. 156 (1996), 899–903.
130. Hsu, L.M., Huang, Y.S., Chang, F.Y., Lee, S.D., 'Fat burner' herb, usnic acid, induced acute hepatitis in a family. J. Gastroenterol. Hepatol. 20:7 (2005), 1138–1139.
131. Hu, Z., Yang, X., Ho, P.C., Chan, S.Y., Heng, P.W., Chan, E., Duan, W., Koh, H.L., Zhou, S., Herb-drug interactions: a literature review. Drugs 65:9 (2005), 1239–1282.
132. Hullar, T.E., Sapers, B.L., Ridker, P.M., Jenkins, R.L., Huth, T.S., Farraye, F.A., Herbal toxicity and fatal hepatic failure. Am. J. Med. 106:2 (1999), 267–268.
133. Humberston, C.L., Akhtar, J., Krenzelok, E.P., Acute hepatitis induced by kava kava. J. Toxicol. Clin. Toxicol. 41:2 (2003), 109–113.
134. Iacovelli, R., Palazzo, A., Procopio, G., Santoni, M., Trenta, P., De Benedetto, A., Mezi, S., Cortesi, E., Incidence and relative risk of hepatic toxicity in patients treated with anti-angiogenic tyrosine kinase inhibitors for malignancy. Br. J. Clin. Pharmacol. 77:6 (2014), 929–938.
135. Jacobsen, C., Semb, S., Kromann-Andersen, H., Toxic hepatitis following consumption of the herbal medicinal product Cascara Sagrada. Ugeskr. Laeger 171 (2009), 3367–3369 Danish.
136. Jeukendrup, A.E., Randell, R., Fat burners: nutrition supplements that increase fat metabolism. Obes. Rev. 12:10 (2011), 841–851.
137. Jibrin, I., Erinle, A., Saidi, A., Aliyu, Z.Y., Saw palmetto-induced pancreatitis. South Med. J. 99:6 (2006), 611–612.
138. Jiménez-Encarnación, E., Ríos, G., Muñoz-Mirabal, A., Vilá, L.M., Euforia-induced acute hepatitis in a patient with scleroderma. BMJ Case Rep., 2012 pii: bcr2012006907.
139. Jimenez-Saenz, M., Martinez-Sanchez Mdel, C., Acute hepatitis associated with the use of green tea infusions. J. Hepatol. 44:3 (2006), 616–617.
140. Jóhannsson, M., Ormarsdóttir, S., Olafsson, S., [Hepatotoxicity associated with the use of Herbalife]. [Article Icel. Laeknabladid 96:3 (2010), 167–172.
141. Johnston, D.I., Chang, A., Viray, M., Chatham-Stephens, K., He, H., Taylor, E., Wong, L.L., Schier, J., Martin, C.2, Fabricant, D., Salter, M., Lewis, L., Park, S.Y., Hepatotoxicity associated with the dietary supplement OxyELITE Pro™ - Hawaii, 2013. Drug Test. Anal.(3–4), 2016, 319–327.
142. Jones, F.J., Andrews, A.H., Acute liver injury associated with the herbal supplement hydroxycut in a soldier deployed to Iraq. Am. J. Gastroenterol. 102:10 (2007), 2357–2358.
143. Joshi, D., Cross, T.J., Wong, V.S., Acute drug induced hepatitis secondary to a weight loss product purchased over the internet. Nutr. J., 6, 2007, 13.
144. Joy, D., Joy, J., Duane, P., Black cohosh: a cause of abnormal postmenopausal liver function tests. Climacteric 11:1 (2008), 84–88.
145. Jorge, O.A., Jorge, A.D., Hepatotoxicity associated with the ingestion of Centella asiatica. Rev. Esp. Enferm. Dig. 97:2 (2005), 115–124.
146. Kafrouni, M.I., Anders, R.A., Verma, S., Hepatotoxicity associated with dietary supplements containing anabolic steroids. Clin. Gastroenterol. Hepatol. 5:7 (2007), 809–812.
147. Kanat, O., Ozet, A., Ataergin, S., Aloe vera-induced acute toxic hepatitis in a healthy young man. Eur. J. Intern Med., 17, 2006, 589.
148. Kaplowitz, N., Causality assessment versus guilt-by-association in drug hepatotoxicity. Hepatology 33:1 (2001), 308–310.
149. Kaplowitz, N., Drug-induced liver injury. Clin. Infect. Dis. 1:38 (2004), S44–S48 Suppl 2.
150. Kaswala, D., Shah, S., Patel, N., Raisoni, S., Swaminathan, S., Hydroxycut-induced liver toxicity. Ann. Med. Health Sci. Res. 4:1 (2014), 143–145.
151. Katz, M., Saibil, F., Herbal hepatitis: subacute hepatic necrosis secondary to chaparral leaf. J. Clin. Gastroenterol. 12:2 (1990), 203–206.
152. Kawaguchi, T., Harada, M., Arimatsu, H., Nagata, S., Koga, Y., Kuwahara, R., Hisamochi, A., Hino, T., Taniguchi, E., Kumemura, H., Hanada, S., Maeyama, M., Koga, H., Tomiyasu, N., Toyomasu, H., Kawaguchi, M., Kage, M., Kumashiro, R., Tanikawa, K., Sata, M., Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases. J. Gastroenterol. Hepatol. 19:3 (2004), 349–350.
153. Kawata, K., Takehira, Y., Kobayashi, Y., Kitagawa, M., Yamada, M., Hanajima, K., Murohisa, G., Kawamura, M., Iwaoka, Y., Wada, T., Morita, S., Iwaizumi, M., Makino, S., Three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement for weight loss. Intern Med. 42:12 (2003), 1188–1192.
154. Kauma, H., Koskela, R., Mäkisalo, H., Autio-Harmainen, H., Lehtola, J., Höckerstedt, K., Toxic acute hepatitis and hepatic fibrosis after consumption of chaparral tablets. Scand. J. Gastroenterol. 39:11 (2004), 1168–1171.
155. Kim, S.Y., Yim, H.J., Ahn, J.H., Kim, J.H., Kim, J.N., Yoon, I., Kim, D.I., Lee, H.S., Lee, S.W., Choi, J.H., Two cases of toxic hepatitis caused by arrowroot juice. Korean J. Hepatol. 15:4 (2009), 504–509 [Article in Korean].
156. Kockler, D.R., McCarthy, M.W., Lawson, C.L., Seizure activity and unresponsiveness after hydroxycut ingestion. Pharmacotherapy 21:5 (2001), 647–651.
157. Kowalski, T.E., Falestiny, M., Furth, E., Malet, P.F., Vitamin A hepatotoxicity: a cautionary note regarding 25,000 IU supplements. Am. J. Med. 97:6 (1994), 523–528.
158. Kraft, M., Spahn, T.W., Menzel, J., Senninger, N., Dietl, K.H., Herbst, H., Domschke, W., Lerch, M.M., Fulminant liver failure after administration of the herbal antidepressant Kava-Kava. Dtsch. Med. Wochenschr 126:36 (2001), 970–972 [Article in German].
159. Krishna, K.P., The efficacy of Ayurvedic treatment for rheumatoid arthritis: cross-sectional experiential profile of a longitudinal study. Int. J. Ayurveda Res. 2:1 (2011), 8–13.
160. Krishnan, P.V., Feng, Z.Z., Gordon, S.C., Prolonged intrahepatic cholestasis and renal failure secondary to anabolic androgenic steroid-enriched dietary supplements. J. Clin. Gastroenterol. 43:7 (2009), 672–675.
161. Laczek, J., Duncan, M., Three cases of acute hepatitis in patients taking hydroxycut bodybuilding supplement. Am. J. Gastroenterol. 103 (2008), S143–S144.
162. Lai, R.T., Wang, H., Gui, H.L., Ye, M.Z., Dai, W.J., Xiang, X.G., Zhao, G.D., Wang, W.J., Xie, Q., Clinical and pathological features in 138 cases of drug-induced liver injury. Zhonghua Gan Zang Bing Za Zhi 20:3 (2012), 185–189 [Article in Chinese].
163. Laliberte, L., Villeneuve, J.P., Hepatitis after the use of germander, a herbal remedy. CMAJ 154:11 (1996), 1689–1692.
164. Lapi, F., Gallo, E., Giocaliere, E., Vietri, M., Baronti, R., Pieraccini, G., Tafi, A., Menniti-Ippolito, F., Mugelli, A., Firenzuoli, F., Vannacci, A., Acute liver damage due to Serenoa repens: a case report. Br. J. Clin. Pharmacol. 69:5 (2010), 558–560.
165. Larrey, D., Hepatotoxicity of herbal remedies. J. Hepatol. 26:Suppl. 1 (1997), 47–51.
166. Larrey, D., Pageaux, G.P., Drug-induced acute liver failure. Eur. J. Gastroenterol. Hepatol. 17:2 (2005), 141–143.
167. Larrey, D., Vial, T., Pauwels, A., Castot, A., Biour, M., David, M., Michel, H., Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann. Intern Med. 117:2 (1992), 129–132.
168. Lee, J., Lee, M.S., Nam, K.W., Acute toxic hepatitis caused by an aloe vera preparation in a young patient: a case report with a literature review. Korean J. Gastroenterol. 64:1 (2014), 54–58.
169. Lee, J.S., Cheong, H.S., Kim, L.H., Kim, J.O., Seo, D.W., Kim, Y.H., Chung, M.W., Han, S.Y., Shin, H.D., Screening of genetic polymorphisms of CYP3A4 and CYP3A5 genes. Korean J. Physiol. Pharmacol. 17:6 (2013), 479–484.
170. Lee, W.M., Acute liver failure. Semin. Respir. Crit. Care Med. 33:1 (2012), 36–45.
171. Legoux, J.L., Maitre, F., Labarrière, D., Gargot, D., Festin, D., Causse, X., Cytolytic hepatitis and wild Germander: a new case with reintroduction. Gastroenterol. Clin. Biol. 16:10 (1992), 813–815 [Article in French].
172. Leise, M.D., Poterucha, J.J., Talwalkar, J.A., Drug-induced liver injury. Mayo Clin. Proc. 89:1 (2014), 95–106.
173. Lemaigre, G., Tebbi, Z., Galinsky, R., Michowitcz, S., Abelanet, R., Fulminating hepatitis caused by glue thistle (Atractylis glummifera-L.), poisoning. Anatomo-pathological study of 4 cases. Nouv. Presse Med. 4:40 (1975 Nov 22), 2565–2568 [Article in French].
174. Levitsky, J., Alli, T.A., Wisecarver, J., Sorrell, M.F., Fulminant liver failure associated with the use of black cohosh. Dig. Dis. Sci. 50:3 (2005), 538–539.
175. Licatta, A., Macaluso, F.S., Craxì, A., Herbal hepatotoxicity: a hidden epidemic. Intern Emerg. Med. 8:1 (2013), 13–22.
176. Licatta, A., Maida, M., Cabibi, D., Butera, G., Macaluso, F.S., Alessi, N., Caruso, C., Craxì, A., Almasio, P.L., Clinical features and outcomes of patients with drug-induced autoimmune hepatitis: a retrospective cohort study. Dig. Liver Dis. 46:12 (2014), 1116–1120.
177. Linnebur, S.A., Rapacchietta, O.C., Vejar, M., Hepatotoxicity associated with Chinese skullcap contained in Move Free Advanced dietary supplement: two case reports and review of the literature. Pharmacotherapy, 30(7), 2010 750, 258e-262e.
178. Lobb, A., Hepatoxicity associated with weight-loss supplements: a case for better post-marketing surveillance. World J. Gastroenterol. 15:14 (2009), 1786–1787.
179. Lonie, T.C., Excess vitamin A as a cause of food poisoning. N. Z. Med. J. 49:274 (1950), 680–685.
180. Long, J., USPlabs to Eliminate Aegeline from Supplements amid Hepatitis Probe. 11/7/2013 http://www.naturalproductsinsider.com/news/2013/11/usplabs-to-eliminate-aegeline-from-supplements-am.aspx (accessed 15.12.15.).
181. Lontos, S., Jones, R.M., Angus, P.W., Gow, P.J., Acute liver failure associated with the use of herbal preparations containing black cohosh. Med. J. Aust. 179:7 (2003), 390–391.
182. Lucena, M.I., Molokhia, M., Shen, Y., Urban, T.J., Aithal, G.P., Andrade, R.J., Day, C.P., Ruiz-Cabello, F., Donaldson, P.T., Stephens, C., Pirmohamed, M., Romero-Gomez, M., Navarro, J.M., Fontana, R.J., Miller, M., Groome, M., Bondon-Guitton, E., Conforti, A., Stricker, B.H., Carvajal, A., Ibanez, L., Yue, Q.Y., Eichelbaum, M., Floratos, A., Pe'er, I., Daly, M.J., Goldstein, D.B., Dillon, J.F., Nelson, M.R., Watkins, P.B., Daly, A.K., Spanish DILI Registry; Eudragene; Dilin; Diligen; International SAEC. Susceptibility to amoxicillin-clavulanate-induced liver injury is influenced by multiple HLA class I and II alleles. Gastroenterology 141:1 (2011), 338–347.
183. Luu, L. Liver transplants. Practice essentials. http://emedicine.medscape.com/article/776313-overview. (accessed 23.11.15.).
184. Lyford, C.L., Vergara, G.G., Moeller, D.D., Hepatic veno-occlusive disease originating in Ecuador. Gastroenterology 70:1 (1976), 105–108.
185. Lynch, C.R., Folkers, M.E., Hutson, W.R., Fulminant hepatic failure associated with the use of black cohosh: a case report. Liver Transpl. 126 (2006), 989–992.
186. MacGregor, F.B., Abernethy, V.E., Dahabra, S., Cobden, I., Hayes, P.C., Hepatotoxicity of herbal remedies. BMJ 299:6708 (1989), 1156–1157.
187. Mahady, G.B., Low Dog, T., Barrett, M.L., Chavez, M.L., Gardiner, P., Ko, R., Marles, R.J., Pellicore, L.S., Giancaspro, G.I., Sarma, D.N., United States Pharmacopeia review of the black cohosh case reports of hepatotoxicity. Menopause 15:4 Pt 1 (2008), 628–638.
188. Mahady, G., Low Dog, T., Sarma, D.N., Giancaspro, G.I., Suspected black cohosh hepatotoxicity–causality assessment versus safety signal. Maturitas 64:2 (2009 Oct 20), 139–140 author reply 141–2.
189. ® products and liver injury. Pharmacoepidemiol. Drug Saf. 20:10 (2011), 1080–1087.
190. Marcus, D.M., Grollman, A.P., Botanical medicines–the need for new regulations. N. Engl. J. Med. 347:25 (2002), 2073–2076.
191. Maria, V.A., Victorino, R.M., Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 26 (1997), 664–669.
192. Mattéi, A., Rucay, P., Samuel, D., Feray, C., Reynes, M., Bismuth, H., Liver transplantation for severe acute liver failure after herbal medicine (Teucrium polium) administration. J. Hepatol., 22(5), 1995, 597.
193. Mattéi, A., Bizollon, T., Charles, J.D., Debat, P., Fontanges, T., Chevallier, M., Trepo, C., Liver damage induced by the ingestion of a product of phytotherapy containing wild germander. Four cases. Gastroenterol. Clin. Biol. 16:10 (1992), 798–800 [Article in French].
194. Mazokopakis, E., Lazaridou, S., Tzardi, M., Mixaki, J., Diamantis, I., Ganotakis, E., Acute cholestatic hepatitis caused by Teucrium polium L. Phytomedicine 11:1 (2004), 83–84.
195. Mazzanti, G., Di Sotto, A., Vitalone, A., Hepatotoxicity of green tea: an update. Arch. Toxicol. 89:8 (2015), 1175–1191.
196. McDonnell, W.M., Bhattacharya, R., Halldorson, J.B., Fulminant hepatic failure after use of the herbal weight-loss supplement exilis. Ann. Intern Med. 151:9 (2009), 673–674.
197. McGuffin, M., Illegally marketed drug ingredients are not dietary supplements. JAMA Intern Med. 173:22 (2013), 2090–2091.
198. Mengual-Moreno, E., Lizarzábal-García, M., Ruiz-Soler, M., Silva-Suarez, N., Andrade-Bellido, R., Lucena-González, M., Bessone, F., Hernández, N., Sánchez, A., Medina-Cáliz, I., Case reports of drug-induced liver injury in a reference hospital of Zulia state, Venezuela. Invest Clin. 56:1 (2015), 3–12 [Article in Spanish].
199. Miksad, R., de Lédinghen, V., McDougall, C., Fiel, I., Rosenberg, H., Hepatic hydrothorax associated with vitamin a toxicity. J. Clin. Gastroenterol. 34:3 (2002), 275–279.
200. Millonig, G., Stadlmann, S., Vogel, W., Herbal hepatotoxicity: acute hepatitis caused by a Noni preparation (Morinda citrifolia). Eur. J. Gastroenterol. Hepatol. 17:4 (2005), 445–447.
201. Mimidis, K.P., Papadopoulos, V.P., Baltatzidis, G., Giatromanolaki, A., Sivridis, E., Kartalis, G., Severe acute cholestasis caused by Teucrium polium. J. Gastrointestin Liver Dis. 18:3 (2009), 387–388.
202. Minuk, G.Y., Kelly, J.K., Hwang, W.S., Vitamin A hepatotoxicity in multiple family members. Hepatology 8:2 (1988), 272–275.
203. Molinari, M., Watt, K.D., Kruszyna, T., Nelson, R., Walsh, M., Huang, W.Y., Nashan, B., Peltekian, K., Acute liver failure induced by green tea extracts: case report and review of the literature. Liver Transpl. 12:12 (2006), 1892–1895.
204. Moro, P.A., Cassetti, F., Giugliano, G., Falce, M.T., Mazzanti, G., Menniti-Ippolito, F., Raschetti, R., Santuccio, C., Hepatitis from Greater celandine (Chelidonium majus L.): review of literature and report of a new case. J. Ethnopharmacol. 124:2 (2009), 328–332.
205. Mostefa-Kara, N., Pauwels, A., Pines, E., Biour, M., et al. Fatal hepatitis after herbal tea. Lancet, 340(8820), 1992, 674.
206. Mounajjed, T., Graham, R.P., Sanderson, S.O., Smyrk, T.C., Clinical associations of hepatic stellate cell (HSC) hyperplasia. Virchows Arch. 465:1 (2014), 57–65.
207. Mrzljak, A., Kosuta, I., Skrtic, A., Kanizaj, T.F., Vrhovac, R., Drug-induced liver injury associated with noni (Morinda citrifolia) juice and phenobarbital. Case Rep. Gastroenterol. 7 (2013), 19–24.
208. Munoz, S.J., Fariello, R., Maddrey, W.C., Submassive hepatic necrosis associated with the use of progabide: a GABA receptor agonist. Dig. Dis. Sci. 33:3 (1988), 375–380.
209. Muqeet Adnan, M., Khan, M., Hashmi, S., Hamza, M., AbdulMujeeb, S., Amer, S., Black cohosh and liver toxicity: is there a relationship?. Case Rep. Gastrointest. Med., 2014, 2014, 860614.
210. Nadir, A., Agrawal, S., King, P.D., Marshall, J.B., Acute hepatitis associated with the use of a Chinese herbal product, ma-huang. Am. J. Gastroenterol. 91:7 (1996), 1436–1438.
211. Nadir, A., Reddy, D., Van Thiel, D.H., Cascara sagrada-induced intrahepatic cholestasis causing portal hypertension: case report and review of herbal hepatotoxicity. Am. J. Gastroenterol. 95:12 (2000), 3634–3637.
212. Nakasone, E.S., Tokeshi, J., A serendipitous find: a case of cholangiocarcinoma identified incidentally after acute liver injury due to cascara sagrada ingestion. Hawaii J. Med. Public Health 74:6 (2015), 200–202.
213. Nam, S.W., Baek, J.T., Lee, D.S., Kang, S.B., Ahn, B.M., Chung, K.W., A case of acute cholestatic hepatitis associated with the seeds of Psoralea corylifolia (Boh-Gol-Zhee). Clin. Toxicol. (Phila) 43:6 (2005), 589–591.
214. Naranjo, C.A., Busto, U., Sellers, E.M., Sandor, P., Ruiz, I., Roberts, E.A., Janecek, E., Domecq, C., Greenblatt, D.J., A method for estimating the probability of adverse drug reactions. Clin. Pharmacol. Ther. 30:2 (1981), 239–245.
215. Navarro, V.J., Bonkovsky, H.L., Hwang, S.I., Vega, M., Barnhart, H., Serrano, J., Catechins in dietary supplements and hepatotoxicity. Dig. Dis. Sci. 58:9 (2013), 2682–2690.
216. Navarro, V.J., Lucena, M.I., Hepatotoxicity induced by herbal and dietary supplements. Semin. Liver Dis. 34:2 (2014), 172–193.
217. Navarro, V.J., Barnhart, H., Bonkovsky, H.L., Davern, T., Fontana, R.J., Grant, L., Reddy, K.R., Seeff, L.B., Serrano, J., Sherker, A.H., Stolz, A., Talwalkar, J., Vega, M., Vuppalanchi, R., Liver injury from herbals and dietary supplements in the U.S. Drug-Induced Liver Injury Network. Hepatology 60:4 (2014), 1399–1408.
218. Navarro, V.J., Seeff, L.B., Liver injury induced by herbal complementary and alternative medicine. Clin. Liver Dis. 17:4 (2013), 715–735.
219. Neergheen-Bhujun, V.S., Underestimating the toxicological challenges associated with the use of herbal medicinal products in developing countries. Biomed. Res. Int., 2013, 2013, 804086.
220. Neff, G.W., Reddy, K.R., Durazo, F.A., Meyer, D., Marrero, R., Kaplowitz, N., Severe hepatotoxicity associated with the use of weight loss diet supplements containing ma huang or usnic acid. J. Hepatol. 41:6 (2004), 1062–1064.
221. Nencini, C., Galluzzi, P., Pippi, F., Menchiari, A., Micheli, L., Hepatotoxicity of Teucrium chamaedrys L. decoction: role of difference in the harvesting area and preparation method. Indian J. Pharmacol. 46:2 (2014), 181–184.
222. Nisbet, B.C., O'Connor, R.E., Black cohosh-induced hepatitis. Del Med. J. 79:11 (2007), 441–444.
223. Nortadas, R., Barata, J., Fulminant hepatitis during self-medication with conjugated linoleic acid. Ann. Hepatol. 11:2 (2012), 265–267.
224. Nowack, R., Nowak, B., Herbal teas interfere with cyclosporin levels in renal transplant patients. Nephrol. Dial. Transpl. 20:11 (2005), 2554–2556.
225. O'Donnell, J., Polar hysteria: an expression of hypervitaminosis A. Am. J. Ther. 11:6 (2004), 507–516.
226. O'hara, M., Kiefer, D., Farrell, K., Kemper, K., et al. A review of 12 commonly used medicinal herbs. Arch. Fam. Med. 7:6 (1998), 523–536.
227. Ortiz Cansado, A., Crespo Valadés, E., Morales Blanco, P., Sáenz de Santamaría, J., González Campillejo, J.M., Ruiz Téllez, T., Veno-occlusive liver disease due to intake of Senecio vulgaris tea. Gastroenterol. Hepatol. 18:8 (1995), 413–416 [Article in Spanish].
228. Ossendza, R.A., Grandval, P., Chinoune, F., Rocher, F., Chapel, F., Bernardini, D., Acute cholestatic hepatitis due to glucosamine forte. Gastroenterol. Clin. Biol. 31:4 (2007), 449–450 [Article in French].
229. Patel, D.N., Low, W.L., Tan, L.L., Tan, M.M., Zhang, Q., Low, M.Y., Chan, C.L., Koh, H.L., Adverse events associated with the use of complementary medicine and health supplements: an analysis of reports in the Singapore Pharmacovigilance database from 1998 to 2009. Clin. Toxicol. (Phila) 50:6 (2012), 481–489.
230. Patel, S.S., Beer, S., Kearney, D.L., Phillips, G., Carter, B.A., Green tea extract: a potential cause of acute liver failure. World Gastroenterol. 19:31 (2013), 5174–5177.
231. Pauwels, A., Thierman-Duffaud, D., Azanowsky, J.M., Loiseau, D., Biour, M., Levy, V.G., Acute hepatitis caused by wild germander. Hepatotoxicity of herbal remedies. Two cases. Gastroenterol. Clin. Biol. 16:1 (1992), 92–95 [Article in French].
232. PDR Staff, Physicians' Desk Reference. 70th Edition, 2016, PDR Network.
233. Pedrós, C., Cereza, G., García, N., Laporte, J.R., Liver toxicity of Camellia sinensis dried etanolic extract. Med. Clin. Barc. 121:15 (2003), 598–599 [Article in Spanish].
234. Pérez Alvarez, J., Sáez-Royuela, F., Gento Peña, E., López Morante, A., Velasco Osés, A., Martín Lorente, J., Acute hepatitis due to ingestion of Teucrium chamaedrys infusions. Gastroenterol. Hepatol. 24:5 (2001), 240–243 [Article in Spanish].
235. Picciotto, A., Campo, N., Brizzolara, R., Giusto, R., et al. Chronic hepatitis induced by jin bu huan. J. Hepatol. 28:1 (1998), 156–157.
236. Pierard, S., Coche, J.C., Lanthier, P., Dekoninck, X., Lanthier, N., Rahier, J., Geubel, A.P., Severe hepatitis associated with the use of black cohosh: a report of two cases and an advice for caution. Eur. J. Gastroenterol. Hepatol. 21:8 (2009), 941–945.
237. Pillukat, M.H., Bester, C., Hensel, A., Lechtenberg, M., Petereit, F., Beckebaum, S., Müller, K.M., Schmidt, H.H., Concentrated green tea extract induces severe acute hepatitis in a 63-year-old woman–a case report with pharmaceutical analysis. J. Ethnopharmacol. 155:1 (2014), 165–170.
238. Pittler, M.H., Ernst, E., Systematic review: hepatotoxic events associated with herbal medicinal products. Aliment. Pharmacol. Ther. 18:5 (2003), 451–471.
239. Polymeros, D., Kamberoglou, D., Tzias, V., Acute cholestatic hepatitis caused by Teucrium polium (golden germander) with transient appearance of antimitochondrial antibody. J. Clin. Gastroenterol. 34:1 (2002), 100–101.
240. Poon, W.T., Chau, T.L., Lai, C.K., Tse, K.Y., Chan, Y.C., Leung, K.S., Chan, Y.W., Hepatitis induced by Teucrium viscidum. Clin. Toxicol. (Phila) 46:9 (2008), 819–822.
241. Posadzki, P., Watson, L., Ernst, E., Herb-drug interactions: an overview of systematic reviews. Br. J. Clin. Pharmacol. 75:3 (2013), 603–618.
242. Rabe, C., Musch, A., Schirmacher, P., Kruis, W., Hoffmann, R., Acute hepatitis induced by an aloe vera preparation: a case report. World J. Gastroenterol. 11 (2005), 303–304.
243. Rader, J.I., Calvert, R.J., Hathcock, J.N., Hepatic toxicity of unmodified and time-release preparations of niacin. Am. J. Med. 92:1 (1992), 77–81.
244. Rahimi, R., Abdollahi, M., An update on the ability of St. John's wort to affect the metabolism of other drugs. Expert Opin. Drug Metab. Toxicol. 8:6 (2012), 691–708.
245. Rahnema, C.D., Crosnoe, L.E., Kim, E.D., Designer steroids - over-the-counter supplements and their androgenic component: review of an increasing problem. Andrology 3:2 (2015), 150–155.
246. Ramanathan, V.S., Hensley, G., French, S., Eysselein, V., Chung, D., Reicher, S., Pham, B., Hypervitaminosis A inducing intra-hepatic cholestasis–a rare case report. Exp. Mol. Pathol. 88:2 (2010), 324–325.
247. Ramanathan, V.S., Mitropoulos, E., Shlopov, B., Eysselein, V., Chung, D., Reicher, S., Pham, B.V., An Enzyte'ing' case of acute hepatitis. J. Clin. Gastroenterol. 45:9 (2011), 834–835.
248. Ramos, R., Mascarenhas, J., Duarte, P., Vicente, C., Casteleiro, C., Conjugated linoleic acid-induced toxic hepatitis: first case report. Dig. Dis. Sci. 54:5 (2009), 1141–1143.
249. Raschi, E., De Ponti, F., Drug- and herb-induced liver injury: progress, current challenges and emerging signals of post-marketing risk. World J. Hepatol. 7:13 (2015), 1761–1771.
250. Rashid, N.N., Grant, J., Hydroxycut hepatotoxicity. Med. J. Aust. 192:3 (2010), 173–174.
251. Ridker, P.M., Ohkuma, S., McDermott, W.V., Trey, C., Huxtable, R.J., Hepatic venocclusive disease associated with the consumption of pyrrolizidine-containing dietary supplements. Gastroenterology 88:4 (1985), 1050–1054.
252. Rifai, K., Flemming, P., Manns, M.P., Trautwein, C., Severe drug hepatitis caused by Chelidonium. Internist (Berl) 47:7 (2006), 749–751 [Article in German].
253. Roeder, E., Medicinal plants in China containing pyrrolizidine alkaloids. Pharmazie 55:10 (2000), 711–726.
254. Rohilla, R., Garg, T., Goyal, A.K., Rath, G., Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. 23:5 (2016), 1645–1661.
255. Roselle, H., Ekatan, A., Tzeng, J., Sapienza, M., Kocher, J., Symptomatic hepatitis associated with the use of herbal red yeast rice. Ann. Intern Med. 149:7 (2008), 516–517.
256. Roytman, M.M., Pörzgen, P., Lee, C.L., Huddleston, L., Kuo, T.T., Bryant-Greenwood, P., Wong, L.L., Tsai, N., Outbreak of severe hepatitis linked to weight-loss supplement OxyELITE Pro. Am. J. Gastroenterol. 109:8 (2014), 1296–1298.
257. Russmann, S., Lauterburg, B.H., Helbling, A., Kava hepatotoxicity. Ann. Intern Med. 135:1 (2001), 68–69.
258. Russo, M.W., Galanko, J.A., Shrestha, R., Fried, M.W., Watkins, P., Liver transplantation for acute liver failure from drug induced liver injury in the United States. Liver Transpl. 10:8 (2004), 1018–1023.
259. Safi, K.H., Filbrun, A.G., Nasr, S.Z., Hypervitaminosis A causing hypercalcemia in cystic fibrosis. Case report and focused review. Ann. Am. Thorac. Soc. 11:8 (2014), 1244–1247.
260. Sanchez, W., Maple, J.T., Burgart, L.J., Kamath, P.S., Severe hepatotoxicity associated with use of a dietary supplement containing usnic acid. Mayo Clin. Proc. 81:4 (2006), 541–544.
261. Sansone, R.A., Sansone, L.A., Carrot man: a case of excessive beta-carotene ingestion. Int. J. Eat. Disord. 45:6 (2012), 816–818.
262. Sarma, D.N., Barrett, M.L., Chavez, M.L., Gardiner, P., Ko, R., Mahady, G.B., Marles, R.J., Pellicore, L.S., Giancaspro, G.I., Low Dog, T., Safety of green tea extracts: a systematic review by the US Pharmacopeia. Drug Saf. 31:6 (2008), 469–484.
263. Savvidou, S., Goulis, J., Giavazis, I., Patsiaoura, K., Hytiroglou, P., Arvanitakis, C., Herb-induced hepatitis by Teucrium polium L.: report of two cases and review of the literature. Eur. J. Gastroenterol. Hepatol. 19:6 (2007), 507–511.
264. Schiano, T.D., Hepatotoxicity and complementary and alternative medicines. Clin. Liver Dis. 7:2 (2003), 453–473.
265. Schoepfer, A.M., Engel, A., Fattinger, K., Marbet, U.A., Criblez, D., Reichen, J., Zimmermann, A., Oneta, C.M., Herbal does not mean innocuous: ten cases of severe hepatotoxicity associated with dietary supplements from Herbalife products. J. Hepatol. 47:4 (2007), 521–526.
266. Scott, B.A., Troppmann, C., Rossaro, L., Hepatotoxicity associated with a dietary supplement. Ann. Intern Med., 138(8), 2003 W-W49.
267. Seeff, L.B., Bonkovsky, H.L., Navarro, V.J., Wang, G., Herbal products and the liver: a review of adverse effects and mechanisms. Gastroenterology 148:3 (2015), 517–532.
268. Semwal, R.B., Semwal, D.K., Vermaak, I., Viljoen, A., A comprehensive scientific overview of Garcinia cambogia. Fitoterapia 102 (2015), 134–148.
269. Seybold, U., Landauer, N., Hillebrand, S., Goebel, F.D., Senna-induced hepatitis in a poor metabolizer. Ann. Intern Med. 141:8 (2004), 650–651.
270. Sezer, R.G., Bozaykut, A., Pediatric hepatotoxicity associated with polygermander (teucrium polium). Clin. Toxicol. (Phila), 50(2), 2012, 153.
271. Shad, J.A., Chinn, C.G., Brann, O.S., Acute hepatitis after ingestion of herbs. South Med. J. 92:11 (1999), 1095–1097.
272. Shah, N.L., Zacharias, I., Khettry, U., Afdhal, N., Gordon, F.D., Methasteron-associated cholestatic liver injury: clinicopathologic findings in 5 cases. Clin. Gastroenterol. Hepatol. 6:2 (2008), 255–258.
273. ®) (herbal weight loss supplement) induced hepatotoxicity: a case report and review of literature. Hawaii Med. J. 69:8 (2010), 188–190.
274. Sheikh, N.M., Philen, R.M., Love, L.A., Chaparral-associated hepatotoxicity. Arch. Intern Med. 157:8 (1997), 913–919.
275. Sheth, A., Khurana, R., Khurana, V., Potential liver damage associated with over-the-counter vitamin supplements. J. Am. Diet. Assoc. 108:9 (2008), 1536–1537.
276. Shim, M., Saab, S., Severe hepatotoxicity due to Hydroxycut: a case report. Dig. Dis. Sci. 54:2 (2009), 406–408.
277. Shipley, A., Berkowitz, B., Rivero, C., Designer Steroids: Hide and Seek. 10/18/2005 The Washington Post http://www.washingtonpost.com/wp-dyn/content/graphic/2005/10/18/GR2005101800648.html (accessed 30.11.15.).
278. Skoulidis, F., Alexander, G.J., Davies, S.E., Ma huang associated acute liver failure requiring liver transplantation. Eur. J. Gastroenterol. Hepatol. 17:5 (2005), 581–584.
279. Smith, A., Dillon, J., Acute liver injury associated with the use of herbal preparations containing glucosamine: three case studies. BMJ Case Rep., 2009, 2009 pii: bcr02.2009.1603.
280. Smith, B.C., Desmond, P.V., Acute hepatitis induced by ingestion of the herbal medication chaparral. Aust. N. Z. J. Med., 23(5), 1993, 526.
281. Soni, M.G., Burdock, G.A., Preuss, H.G., Stohs, S.J., Ohia, S.E., Bagchi, D., Safety assessment of (-)-hydroxycitric acid and Super CitriMax, a novel calcium/potassium salt. Food Chem. Toxicol. 42:9 (2004), 1513–1529.
282. Sonmez, A., Yilmaz, M.I., Mas, R., Ozcan, A., Celasun, B., Dogru, T., Taslipinar, A., Kocar, I.H., Subacute cholestatic hepatitis likely related to the use of senna for chronic constipation. Acta Gastroenterol. Belg 68:3 (2005), 385–387.
283. Stadlbauer, V., Weiss, S., Payer, F., Stauber, R.E., Herbal does not at all mean innocuous: the sixth case of hepatotoxicity associated with morinda citrifolia (noni). Am. J. Gastroenterol. 103:9 (2008), 2406–2407.
284. Stadlbauer, V., Fickert, P., Lackner, C., Schmerlaib, J., Krisper, P., Trauner, M., Stauber, R.E., Hepatotoxicity of NONI juice: report of two cases. World J. Gastroenterol. 11:30 (2005), 4758–4760.
285. Starakis, I., Siagris, D., Leonidou, L., Mazokopakis, E., Tsamandas, A., Karatza, C., Hepatitis caused by the herbal remedy Teucrium polium L. Eur. J. Gastroenterol. Hepatol. 18:6 (2006), 681–683.
286. Stedman, C., Herbal toxicity. Semin. Liver Dis. 22:2 (2002), 195–206.
287. Steenkamp, V., Stewart, M.J., Zuckerman, M., Detection of poisoning by Impila (Callilepis laureola) in a mother and child. Hum. Exp. Toxicol. 18:10 (1999), 594–597.
288. Stephens, C., López-Nevot, M.Á., Ruiz-Cabello, F., Ulzurrun, E., Soriano, G., Romero-Gómez, M., Moreno-Casares, A., Lucena, M.I., Andrade, R.J., HLA alleles influence the clinical signature of amoxicillin-clavulanate hepatotoxicity. PLoS One, 8(7), 2013 Jul 9, e68111.
289. Stevens, T., Qadri, A., Zein, N.N., Two patients with acute liver injury associated with use of the herbal weight-loss supplement hydroxycut. Ann. Intern Med. 142:6 (2005), 477–478.
290. Stickel, F., Baumüller, H.M., Seitz, K., Vasilakis, D., Seitz, G., Seitz, H.K., Schuppan, D., Hepatitis induced by Kava (Piper methysticum rhizoma). J. Hepatol. 39:1 (2003), 62–67.
291. Stickel, F., Droz, S., Patsenker, E., Bögli-Stuber, K., Aebi, B., Leib, S.L., Severe hepatotoxicity following ingestion of Herbalife nutritional supplements contaminated with Bacillus subtilis. J. Hepatol. 50:1 (2009), 111–117.
292. Stickel, F., Kessebohm, K., Weimann, R., Seitz, H.K., Review of liver injury associated with dietary supplements. Liver Int. 31:5 (2011), 595–605.
293. Stickel, F., Patsenker, E., Schuppan, D., Herbal hepatotoxicity. J. Hepatol. 43:5 (2005), 901–910.
294. Stickel, F., Pöschl, G., Seitz, H.K., Waldherr, R., Hahn, E.G., Schuppan, D., Acute hepatitis induced by greater celandine (chelidonium majus). Scand. J. Gastroenterol. 38:5 (2003), 565–568.
295. Stickel, F., Shouval, D., Hepatotoxicity of herbal and dietary supplements: an update. Arch. Toxicol. 89:6 (2015), 851–865.
296. Stillman, A.E., Huxtable, R.J., Fox, D., Hart, M., Bergeson, P., Pyrrolizidine (Senecio) poisoning in Arizona: severe liver damage due to herbal teas. Ariz Med. 34:8 (1977), 545–546.
297. Stohs, S.J., Ray, S.D., A review and evaluation of the efficacy and safety of Cissus quadrangularis extracts. Phytother. Res. 27:8 (2013), 1107–1114.
298. Stohs, S.J., Preuss, H.G., Ohia, S.E., Kaats, G.R., Keen, C.L., Williams, L.D., Burdock, G.A., No evidence demonstrating hepatotoxicity associated with hydroxycitric acid. World J. Gastroenterol. 15:32 (2009), 4087–4089.
299. Strahl, S., Ehret, V., Dahm, H.H., Maier, K.P., Necrotizing hepatitis after taking herbal remedies. Dtsch. Med. Wochenschr 123:47 (1998), 1410–1414 [Article in German].
300. Strasser, M., Stadlmayr, A., Haufe, H., Stickel, F., Ferenci, P., Patsch, W., Feldman, A., Weghuber, D., Datz, C., Aigner, E., Natural course of subjects with elevated liver tests and normal liver histology. Liver Int., 2015 Aug 10 ([Epub ahead of print]).
301. Suk, K.T., Kim, D.J., Kim, C.H., Park, S.H., et al. A prospective nationwide study of drug-induced liver injury in Korea. Am. J. Gastron. 107 (2012), 1380–1387.
302. Sullivan, J.B. Jr., Rumack, B.H., Thomas, H. Jr., Peterson, R.G., Bryson, P., Pennyroyal oil poisoning and hepatotoxicity. JAMA 242 (1979), 2873–2874.
303. Takegoshi, K., Tohyama, T., Okuda, K., Suzuki, K., Ohta, G., A case of Venoplant-induced hepatic injury. Gastroenterol. Jpn. 21:1 (1986), 62–65.
304. Takikawa, H., Takamori, Y., Kumagi, T., Onji, M., Watanabe, M., Shibuya, A., Hisamochi, A., Kumashiro, R., Ito, T., Mitsumoto, Y., Nakamura, A., Sakaguchi, T., Assessment of 287 Japanese cases of drug induced liver injury by the diagnostic scale of the International Consensus Meeting. Hepatol. Res. 27:3 (2003), 192–195.
305. Tandon, B.N., Tandon, H.D., Tandon, R.K., Narndranathan, M., Joshi, Y.K., An epidemic of veno-occlusive disease of liver in central India. Lancet 2:7980 (1976), 271–272.
306. Teschke, R., Black cohosh and suspected hepatotoxicity: inconsistencies, confounding variables, and prospective use of a diagnostic causality algorithm. A critical review. Menopause 17:2 (2010), 426–440.
307. Teschke, R., Kava hepatotoxicity–a clinical review. Ann. Hepatol. 9:3 (2010), 251–265.
308. Teschke, R., Traditional chinese medicine induced liver injury. J. Clin. Transl. Hepatol. 2:2 (2014), 80–94.
309. Teschke, R., Bahre, R., Severe hepatotoxicity by Indian Ayurvedic herbal products: a structured causality assessment. Ann. Hepatol. 8:3 (2009), 258–266.
310. Teschke, R., Frenzel, C., Schulze, J., Eickhoff, A., Herbal hepatotoxicity: challenges and pitfalls of causality assessment methods. World J. Gastroenterol. 19:19 (2013), 2864–2882.
311. Teschke, R., Frenzel, C., Schulze, J., Schwarzenboeck, A., Eickhoff, A., Herbalife hepatotoxicity: evaluation of cases with positive reexposure tests. World J. Hepatol. 5:7 (2013), 353–363.
312. Teschke, R., Larrey, D., Melchart, D., Dana, G., Traditional Chinese Medicine (TCM) and herbal Hepatotoxicity: RUCAM and the role of novel diagnostic biomarkers such as microRNAs. Medicines, 3(18), 2016, 10.3390/medicines3030018.
313. Teschke, R., Schulze, J., Suspected herbal hepatotoxicity: requirements for appropriate causality assessment by the US Pharmacopeia. Drug Saf. 35:12 (2012), 1091–1097.
314. Teschke, R., Schulze, J., Schwarzenboeck, A., Eickhoff, A., Frenzel, C., Herbal hepatotoxicity: suspected cases assessed for alternative causes. Eur. J. Gastroenterol. Hepatol. 25:9 (2013), 1093–1098.
315. Teschke, R., Schwarzenboeck, A., Hennermann, K.H., Causality assessment in hepatotoxicity by drugs and dietary supplements. Br. J. Clin. Pharmacol. 66:6 (2008), 758–766.
316. Teschke, R., Wolff, A., Frenzel, C., Schulze, J., Eickhoff, A., Herbal hepatotoxicity: a tabular compilation of reported cases. Liver Int. 32:10 (2012), 1543–1556.
317. Theiler, R., Wirth, H.P., Flury, R., Hanck, A., Michel, B.A., Chronic vitamin A poisoning with musculoskeletal symptoms and morphological changes of the liver: a case report. Schweiz Med. Wochenschr 123:51–52 (1993), 2405–2412 [Article in German].
318. Thomasson, H.R., Crabb, D.W., Edenberg, H.J., Li, T.K., Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism. Behav. Genet. 23:2 (1993), 131–136.
319. Urban, T.J., Daly, A.K., Aithal, G.P., Genetic basis of drug-induced liver injury: present and future. Semin. Liver Dis. 34:2 (2014), 123–133.
320. van de Meerendonk, H.W., van Hunsel, F.P., van der Wiel, H.E., Autoimmune hepatitis induced by Actaea racemosa. Side affects of an herb extract. Ned. Tijdschr. Geneeskd. 153:6 (2009), 246–249 [Article in Dutch].
321. Vanderperren, B., Rizzo, M., Angenot, L., Haufroid, V., Jadoul, M., Hantson, P., Acute liver failure with renal impairment related to the abuse of senna anthraquinone glycosides. Ann. Pharmacother. 39:7–8 (2005), 1353–1357.
322. Vannacci, A., Lapi, F., Gallo, E., Vietri, M., Toti, M., Menniti-Ippolito, F., Raschetti, R., Firenzuoli, F., Mugelli, A., A case of hepatitis associated with long-term use of Cimicifuga racemosa. Altern. Ther. Health Med. 15:3 (2009), 62–63.
323. Vassiliadis, T., Anagnostis, P., Patsiaoura, K., Giouleme, O., Katsinelos, P., Mpoumponaris, A., Eugenidis, N., Valeriana hepatotoxicity. Sleep. Med., 10(8), 2009, 935.
324. Vilar, J.H., García, M., Cabrera, P., Veno-occlusive liver disease induced by Senecio vulgaris toxicity. Gastroenterol. Hepatol. 23:6 (2000), 285–286 [Article in Spanish].
325. Vivekanandarajah, A., Ni, S., Waked, A., Acute hepatitis in a woman following excessive ingestion of an energy drink: a case report. J. Med. Case Rep., 22(5), 2011, 227.
326. Voican, C.S., Corruble, E., Naveau, S., Perlemuter, G., Antidepressant-induced liver injury: a review for clinicians. Am. J. Psychiatry 171:4 (2014), 404–415.
327. Vuppalanchi, R., Navarro, V., Vega, M., Bonkovsky, H.L., Seeff, L., Serrano, J., Drug-Induced Liver Injury Network (DILIN). Herbal dietary supplement associated hepatotoxicity: an upcoming workshop and need for research. Gastroenterology 148:3 (2015), 480–482.
328. Wainwright, J., Sconland, M.M., Candy, H.A., Toxicity of Callilepis laureola. S Afr. Med. J. 52:8 (1977), 313–315.
329. Watson, A.R., Coovadia, H.M., Bhoola, K.D., The clinical syndrome of Impila (Callilepis laureola) poisoning in children. S Afr. Med. J. 55:8 (1979), 290–292.
330. Weinstein, D.H., Twaddell, W.S., Raufman, J.P., Philosophe, B., Mindikoglu, A.L., SlimQuick™ - associated hepatotoxicity in a woman with alpha-1 antitrypsin heterozygosity. World J. Hepatol. 4:4 (2012 Apr 27), 154–157.
331. West, B.J., Jensen, C.J., Westendorf, J., White, L.D., A safety review of noni fruit juice. J. Food Sci. 71:8 (2007), R100–R106.
332. West, B.J., Jensen, C.J., Westendorf, J., Noni juice is not hepatotoxic. World J. Gastroenterol. 12:22 (2006), 3616–3619.
333. Weston, C.F., Cooper, B.T., Davies, J.D., Levine, D.F., Veno-occlusive disease of the liver secondary to ingestion of comfrey. Br. Med. J. Clin. Res. Ed., 295(6591), 1987, 183.
334. Whiting, P.W., Clouston, A., Kerlin, P., Black cohosh and other herbal remedies associated with acute hepatitis. Med. J. Aust. 177:8 (2002), 440–443.
335. Whitsett, M., Marzio, D.H., Rossi, S., SlimQuick™-Associated hepatotoxicity resulting in fulminant liver failure and orthotopic liver transplantation. ACG Case Rep. J. 1:4 (2014), 220–222.
336. Woolf, G.M., Petrovic, L.M., Rojter, S.E., Wainwright, S., et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann. Intern Med. 121:10 (1994), 729–735.
337. World Health Organization (WHO). The use of the WHO-UMC system for standardized case causality assessment. http://who-umc.org/Graphics/24734.pdf. (accessed 08.09.15.).
338. Wysowski, D.K., Swartz, L., Adverse drug event surveillance and drug withdrawals in the United States, 1969-2002: the importance of reporting suspected reactions. Arch. Intern Med. 165:12 (2005), 1363–1369.
339. Yang, H.N., Kim, D.J., Kim, Y.M., Kim, B.H., Sohn, K.M., Choi, M.J., Choi, Y.H., Aloe-induced toxic hepatitis. J. Korean Med. Sci. 25 (2010), 492–495.
340. Yang, L., Aronsohn, A., Hart, J., Jensen D.Herbal hepatoxicity from Chinese skullcap: a case report. World J. Hepatol. 4:7 (2012), 231–233.
341. Yang, X.X., Hu, Z.P., Duan, W., Zhu, Y.Z., Zhou, S.F., Drug-herb interactions: eliminating toxicity with hard drug design. Curr. Pharm. Des. 12:35 (2006), 4649–4664.
342. Yeong, M.L., Swinburn, B., Kennedy, M., Nicholson, G., Hepatic veno-occlusive disease associated with comfrey ingestion. J. Gastroenterol. Hepatol. 5:2 (1990), 211–214.
343. Yuan, L., Kaplowitz, N., Mechanisms of drug-induced liver injury. Clin. Liver Dis. 17:4 (2013), 507–518.
344. Yu, K., Geng, X., Chen, M., Zhang, J., Wang, B., Ilic, K., Tong, W., High daily dose and being a substrate of cytochrome P450 enzymes are two important predictors of drug-induced liver injury. Drug Metab. Dispos. 42:4 (2014 Apr), 744–750.
345. Yu, E.L., Sivagnanam, M., Ellis, L., et al. Acute hepatotoxicity after ingestion of Morinda citrifolia (noni berry) juice in a 14-year-old boy. J. Pediatr. Gastroenterol. Nutr. 52 (2011), 222–224.
346. Yuce, B., Gulberg, V., Diebold, J., Gerbes, A.L., Hepatitis induced by Noni juice from Morinda citrifolia: a rare cause of hepatotoxicity or the tip of the iceberg?. Digestion 73:2–3 (2006), 167–170.
347. Zheng, E.X., Navarro, V.J., Liver injury from herbal, dietary, and weight loss supplements: a review. J. Clin. Transl. Hepatol. 3:2 (2015), 93–98.
348. Zhou, Y., Yang, L., Liao, Z., He, X., Zhou, Y., Guo, H., Epidemiology of drug-induced liver injury in China: a systematic analysis of the Chinese literature including 21,789 patients. Eur. J. Gastroenterol. Hepatol. 25:7 (2013), 825–829.
349. Zhou, S.F., Xue, C.C., Yu, X.Q., Li, C., Wang, G., Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome P450 3A4 and the role of therapeutic drug monitoring. Ther. Drug Monit. 29:6 (2007), 687–710.